Lilly launches higher dose vials of weight-loss drug for $150 less than injector pen
Eli Lilly said on Tuesday it has begun selling higher doses of its popular weight-loss drug Zepbound in vials in the U.S. at ...
cnbctv187m
USFDA asks Dr Reddy's to sort out issues at its Hyderabad facility
Dr Reddy's Laboratories Ltd said on February 25 that the American drugs regulator finished inspecting its API manufacturing ...
pharmaphorum6m
Pharma's AI is missing the "Why”
For any company developing AI-powered solutions, the “why” should guide every decision. The technical sophistication of your ...
Judge John Bates Faces Impeachment After Order Against Trump
Bates' ruling was called "so utterly lacking in intellectual honesty and basic integrity that he is guilty of high crimes and ...
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
Eli Lilly is offering higher-dose vials through its direct-to-consumer website, LillyDirect, which started offering lower ...
Ex-Stanford research coordinator convicted of tampering with cancer study database
A jury found Naheed Mangi replaced patient medical data with erroneous information, insults about former boss.
money.rediff48m
USFDA Issues Form 483 to Gland Pharma's Visakhapatnam Unit
USFDA issued a Form 483 with three observations to Gland Pharma's facility in Visakhapatnam after a pre-approval inspection for sterile APIs. The observations are procedural in nature and will be ...